Learn with Anil · APPSC Group-I PYQsPractise online →Subscribe ₹149
LVM3 lifting off with Chandrayaan-3 from Sriharikota, Andhra Pradesh

Photo: LVM3 launch, Sriharikota, ISRO, GODL-India

APPSC Group-I Mains 2023 · Paper V

2023 Paper V · Q8(a): model answer

Science, Technology & Environmental Issues · Biotechnology and health. Held in June 2023 (Notification 28/2022).

Q8(a)10 marks2023 · Paper V

Why is antibiotic resistance getting worse in India? Discuss the strategies and action plans in India to deal with this.

Syllabus: Biotechnology and health · Health and diseases

Model answer · free

Antimicrobial resistanceAntibiotic misuseOne HealthNAP-AMR

Antimicrobial resistance (AMR) arises when bacteria, viruses, fungi and parasites evolve to survive the drugs meant to kill them, so common infections become hard or impossible to treat. Bacterial AMR directly caused about 12.7 lakh deaths worldwide in 2019 (Lancet, 2022). India, among the world's largest consumers of antibiotics, is a hotspot, and has adopted a One Health approach linking human, animal and environmental health.

1. Why antibiotic resistance is getting worse in India

  • Over-the-counter sales and self-medication: antibiotics are bought without prescription and taken for viral fevers, colds and diarrhoea.
  • Irrational prescribing: few rapid diagnostics, patient pressure, irrational fixed-dose combinations, and heavy use of WHO "Watch" antibiotics.
  • Incomplete courses and substandard drugs: they leave the toughest bacteria alive to multiply.
  • Hospital infections: crowded wards and weak infection control spread resistant strains; ICMR surveillance reports resistance even to carbapenems, the drugs of last resort.
  • Animals and environment: antibiotics used in poultry and aquaculture, untreated pharmaceutical effluent and hospital sewage, and poor sanitation spread resistance genes.
  • Empty pipeline: very few new antibiotics are being developed worldwide.
Antibiotic overuse or misuse
Sensitive bacteria die; resistant ones survive
Resistant bacteria multiply and share genes
Spread through hospitals, farms and water
Common infections become untreatable
How misuse breeds superbugs

2. India's strategies and action plans

  • National Action Plan on AMR (2017): six priorities under One Health: awareness, surveillance, infection prevention, rational use in humans and animals, research and investment, and India's leadership.
  • NAP-AMR 2.0 (2025–29): launched in November 2025 to update and accelerate the plan.
  • Regulation: Schedule H1 (2014) requires a prescription register for key antibiotics, the Red Line marks prescription-only antibiotic packs, and colistin was banned as an animal growth promoter (2019).
  • Surveillance and hospitals: ICMR's AMR surveillance network tracks resistance, and stewardship and infection-control programmes (Kayakalp awards for clean hospitals) curb misuse.
  • New drugs and States: nafithromycin (2024), developed in India with BIRAC support, treats resistant pneumonia; Kerala's KARSAP (2018) was the first state action plan.
  1. 2012 Chennai Declaration by medical societies
  2. 2014 Schedule H1 for key antibiotics
  3. 2016 Red Line campaign
  4. 2017 National Action Plan on AMR
  5. 2018 Kerala's KARSAP, the first state plan
  6. 2019 Colistin banned as growth promoter
  7. 2024 Nafithromycin, an Indian-developed antibiotic
  8. 2025 NAP-AMR 2.0 (2025–29)
India's response to AMR

3. Way forward

  • Enforcement: strict prescription-only sales and audits of chemists and hospitals.
  • Prevention: vaccines (typhoid conjugate, pneumococcal), clean water and sanitation reduce the need for antibiotics.
  • Innovation: rapid point-of-care tests and incentives for new antibiotics.
  • Environment and farms: antibiotic limits in pharmaceutical effluent and veterinary stewardship.
  • Awareness: World AMR Awareness Week (18–24 November) and community campaigns.

AP angle: AP produces more than a quarter of India's fish, so curbing antibiotic use in shrimp and fish farms, through residue testing and farm biosecurity, protects both public health and seafood exports.

AMR is a silent pandemic. Only a One Health approach that combines rational use in people and animals, a cleaner environment and new drugs, implemented down to the district, can keep antibiotics working for the next generation.

The other choice in Q8

Answer either one in the exam.

  1. Q8(b)Bio-pesticides are slower in action compared to conventional pesticides, with shorter persistence and susceptible to unfavourable environmental conditions, but still there is a need to shift towards Bio-pesticides - Explain why.

    10 marks · Biotechnology and health · Biotechnology

Write better answers: the Answer Writing Tool Kit

Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149